🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the producers of Tylenol, asserting the corporations withheld alleged dangers that the medication created to children's neurological development.

The lawsuit arrives four weeks after Donald Trump publicized an unproven link between taking Tylenol - also known as acetaminophen - during pregnancy and autism in children.

The attorney general is filing suit against the pharmaceutical giant, which formerly manufactured the medication, the only pain reliever recommended for pregnant women, and the current manufacturer, which now manufacturers it.

In a official comment, he claimed they "deceived the public by making money from discomfort and pushing pills ignoring the risks."

The manufacturer says there is lacking scientific proof linking Tylenol to autism.

"These manufacturers misled for generations, knowingly endangering millions to boost earnings," Paxton, a Republican, said.

Kenvue stated officially that it was "very worried by the dissemination of inaccurate information on the security of acetaminophen and the potential impact that could have on the health of women and children in America."

On its website, Kenvue also stated it had "continuously evaluated the relevant science and there is insufficient valid information that indicates a proven link between using paracetamol and autism spectrum disorder."

Associations acting on behalf of doctors and medical practitioners share this view.

The American College of Obstetricians and Gynecologists has declared acetaminophen - the main ingredient in acetaminophen - is a restricted selection for pregnant women to manage discomfort and fever, which can create serious health risks if ignored.

"In more than two decades of investigation on the use of paracetamol in gestation, not a single reputable study has definitively established that the use of paracetamol in any period of pregnancy causes neurodevelopmental disorders in young ones," the group said.

This legal action cites latest statements from the Trump administration in claiming the drug is potentially dangerous.

Last month, Trump generated worry from medical authorities when he instructed pregnant women to "struggle intensely" not to take Tylenol when unwell.

Federal regulators then published an announcement that medical professionals should contemplate reducing the usage of Tylenol, while also declaring that "a proven link" between the drug and autism in minors has not been established.

The Health Department head Kennedy, who supervises the Food and Drug Administration, had pledged in spring to conduct "extensive scientific investigation" that would determine the origin of autism spectrum disorder in a matter of months.

But specialists advised that identifying a unique factor of autism spectrum disorder - considered by experts to be the result of a complicated interplay of genetic and environmental factors - would be difficult.

Autism is a type of lifelong neurodivergence and condition that affects how individuals encounter and engage with the environment, and is recognized using doctors' observations.

In his legal document, Paxton - a Trump ally who is campaigning for US Senate - asserts the manufacturer and Johnson & Johnson "deliberately disregarded and attempted to silence the science" around paracetamol and autism spectrum disorder.

The lawsuit attempts to require the corporations "remove any marketing or advertising" that states Tylenol is secure for women during pregnancy.

The Texas lawsuit parallels the concerns of a group of guardians of young ones with autism and ADHD who sued the manufacturers of Tylenol in 2022.

A federal judge dismissed the lawsuit, declaring research from the plaintiffs' authorities was lacking definitive proof.